Australia markets closed

Althea Group Holdings Limited (AGH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0260-0.0010 (-3.70%)
At close: 04:10PM AEST

Althea Group Holdings Limited

Suite 2, 360 Elizabeth Street
Level 50
Melbourne, VIC 3000
61 3 9427 7552

IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Joshua Michael FeganCEO, MD & Executive Director824.26kN/AN/A
Mr. Robert MeissnerCFO & Company Secretary442.72kN/AN/A
Mr. David SauerGeneral CounselN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

Corporate governance

Althea Group Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.